Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-19-015882

Options or other derivatives

  • Chief Scientific Officer acquired 82,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Shanler Stuart · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-03-01 Grant or award : show line 1 in the form Restricted stock units +82,200 82,200 D
Loading xslF345X03/doc4.xml…